Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Payables (2020 - 2025)

Historic Payables for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $7146.7 billion.

  • Universe Pharmaceuticals' Payables rose 2202.38% to $7146.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7146.7 billion, marking a year-over-year increase of 2202.38%. This contributed to the annual value of $7146.7 billion for FY2025, which is 2202.38% up from last year.
  • Latest data reveals that Universe Pharmaceuticals reported Payables of $7146.7 billion as of Q3 2025, which was up 2202.38% from $5856.8 billion recorded in Q3 2024.
  • Over the past 5 years, Universe Pharmaceuticals' Payables peaked at $7146.7 billion during Q3 2025, and registered a low of $4.1 million during Q1 2023.
  • Over the past 5 years, Universe Pharmaceuticals' median Payables value was $8.3 million (recorded in 2021), while the average stood at $1625.7 billion.
  • Per our database at Business Quant, Universe Pharmaceuticals' Payables tumbled by 9999.96% in 2021 and then soared by 35552673.36% in 2024.
  • Quarter analysis of 5 years shows Universe Pharmaceuticals' Payables stood at $9.6 million in 2021, then dropped by 27.3% to $7.0 million in 2022, then skyrocketed by 23388.42% to $1.6 billion in 2023, then skyrocketed by 355526.73% to $5856.8 billion in 2024, then rose by 22.02% to $7146.7 billion in 2025.
  • Its Payables stands at $7146.7 billion for Q3 2025, versus $5856.8 billion for Q3 2024 and $4.4 million for Q1 2024.